Ticker Symbol: CELC
Celcuity Inc
$18.34 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001603454
Company Profile
Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies. Celcuity is headquartered in Minneapolis, MN.
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
Website: celcuity.com
CEO: N/A
Tags:
- Commercial Services
- Miscellaneous Commercial Services
- Health Care and Social Assistance
- Medical Laboratories
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $9.98
Change:
-$0.04
(
-0.40%)
Days Range: $9.82 - $10.19
Beta: 0.27
52wk. High: $14.40
52wk. Low: $7.50
Ytd. Change -28.88%
50 Day Moving Average: $9.50
200 Day Moving Average: $10.02
Shares Outstanding: 22090143
Valuation
Market Cap: 22.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A